Global Market Size, Forecast, and Trend Highlights Over 2025-2037
miRNA Tools and Services Market size was valued at USD 456 million in 2024 and is anticipated to surpass USD 3.49 billion by 2037, registering a CAGR of 18.5% during the forecast timeline i.e. 2025-2037. In 2025, the industry size of miRNA tools and services is assessed at USD 540.3 million.
The miRNA products and services market is projected to propel during the stipulated timeframe due to disease exploration such as cancer, neurodegenerative disease, cardiovascular disease, therapeutic research, and personal medicine. For instance, in February 2024, according to the IARC's 2022 report, there were 9.7 million cancer-related deaths worldwide and 20 million new cases. In addition to this, in March 2024, according to a significant study published in the Lancet Neurology, over 3 billion people globally lived with a neurological condition in 2021. Furthermore, a report from the World Heart Federation (WHF) showed that the number of deaths worldwide from cardiovascular disease (CVD) increased from 12.1 million in 1990 to 20.5 million in 2021, reflecting a 60% surge.
Moreover, investment in miRNA research is also fueling the need for biomarker discovery and targeted therapies, as well as the rise in demand for top-notch experimental services such as functional analysis, quantitation, and miRNA isolation. For instance, in January 2025, in a particular type of HR-positive advanced breast cancer, Genentech's Itovebi demonstrated a clinically meaningful and statistically significant overall survival benefit. In addition, the deployment of miRNA reagents on high-throughput platforms and increased use of cloud-based analytics are boosting research output, enabling real-time data sharing, and promoting cooperation among researchers worldwide.
miRNA Tools and Services Sector: Growth Drivers and Challenges
Growth Drivers
- Advancement in sequencing technology: The surging innovations in technology are the impetus for the miRNA tools and services market because of their ability to allow cost-effective and high-throughput miRNA profiling. For instance, in February 2025, Roche announced that it created a new class of next-generation sequencing with the release of its innovative, proprietary sequencing by expansion (SBX) technology. The SBX chemistry, sensor module provides ultra-fast, high-throughput sequencing that is adaptable and scalable for a variety of uses. This technology advancement enhances the sensitivity of miRNA detection and accelerates the discovery of novel miRNA biomarkers.
- Expanding applications in the biomedical field: Increased use of miRNA tools in the miRNA tools and services market is one of the stimulators due to their pivotal position in oncology for therapeutic and prognosis applications. This trend not only propels cancer diagnosis and treatment research but also emphasizes the potential of miRNA-based technologies to develop targeted drugs and personalized treatment schedules. For instance, in October 2024, the robust data visualization tool, BioVisualizer from Excelra revolutionized the researcher’s approach to examining intricate biological data and facilitated more thorough and significant research.
Challenges
- Cost complications: A notable challenge in the miRNA tools and services market is represented by the too-expensive costs of advanced miRNA profiling technologies. The technical sophistication of instrumentation required, reagents, and specialized training necessary for precise measurement of miRNA can pose seemingly insurmountable economic obstacles to the smaller research centers and laboratories. Besides being denied access to the newer miRNA investigative tools, this economic limitation is also deterring the widespread utilization of miRNA tool kits in required research, suppressing innovation and potentially revolutionary insights from arising in the field.
- Intellectual property issues: The issues concerning intellectual property pose an obstacle in the miRNA tools and services market, namely against the competitive environment of biotechnological research and development and patent complexity. As business corporations and researchers attempt to keep their respective miRNA research and technologies confidential, counter-patents and disputes would be an enormous disincentive to technology transfer and collaborations. Uncertainty deterrence detests new investment in research, early firm creation, and entrepreneurship of new tools and services stifles expansion in the field, and limits the scope of use for the benefit of miRNA technology to medicine and therapeutics.
miRNA Tools and Services Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
18.5% |
|
Base Year Market Size (2024) |
USD 456 million |
|
Forecast Year Market Size (2037) |
USD 3.49 billion |
|
Regional Scope |
|
miRNA Tools and Services Segmentation
Products and Services (Research Tools, Services)
Research tool segment is likely to dominate miRNA tools and services market share of around miRNA tools and services % by the end of 2037. As researchers are intensely interested in investigating miRNA functions and their role in biological processes, a stronger emphasis has been placed on higher-level profiling techniques. For instance, in December 2024, Philips CT 5300 integrated cutting-edge hardware, software, and artificial intelligence to enable more patients to access high-quality screening, diagnostic, and interventional imaging. It also offers reading assistance through Automated AI-enabled Philips Advanced Visualization Workspace applications. Thus, the visible presence of research tools on the market indicates their current need for scientific knowledge progress about miRNA biology.
Technology (Extraction Tools, qRT-PCR, NGS, Microarray, Functional Analysis Tools)
Based on the technology, the qRT-PCR segment is expected to garner the major share in the miRNA tools and services market by the end of 2037 because of its unmatched sensitivity and specificity in measuring miRNA expression levels. Researchers attempt to delineate the regulatory function of miRNAs with qRT-PCR which is the preferred method since it can amplify low-abundance miRNAs with high specificity, reproducible and consistent results. For instance, in November 2023, Roche introduced a next-generation qPCR system, LightCycler PRO System to meet public health issues and advance clinical needs in molecular diagnostics. The most cutting-edge qPCR technology’s agility and flexibility for translational research and diagnostics promoted outbreak preparedness and enhanced personalized healthcare.
Our in-depth analysis of the global miRNA tools and services market includes the following segments:
|
Products and Services |
|
|
Technology |
|
|
End user |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportmiRNA Tools and Services Industry - Regional Synopsis
North America Market Statistics
North America miRNA tools and services market is likely to account for revenue share of more than 42.3% by the end of 2037. The market is expanding as a result of the region's emphasis on precision medicine and robust government initiatives. Furthermore, North America's leadership in the market is further cemented by the presence of significant industry players and a proactive approach to implementing cutting-edge technologies.
The U.S. miRNA Tools and Services Market is exponentially growing for innovative developments in the field of miRNA. For instance, in November 2024, as per the news by the National Library of Medicine, Victor Ambros (UMASS Chan Medical School in the US) and Gary Ruvkun (Harvard Medical School in the US) won the 2024 Nobel Prize in Physiology or Medicine for discovering microRNAs (miRNAs). Their groundbreaking discovery has altered our understanding of how non-coding RNAs regulate gene expression.
The Canada miRNA tools and services market is experiencing remarkable growth during the projected timeframe due to regulatory support and investment assistance for the continued development and innovation in therapeutic drugs. For instance, in February 2024, the Government of Canada supported the expansion of RNA technologies & therapeutics to invest in its growth. In addition to this, Canada Economic Development (CED) provides USD 200,000 in financial support to RNA T&T.
Asia Pacific Market Analysis
The Asia Pacific miRNA tools and services market is growing at a remarkable pace due to the region's sizable patient population, which makes it easier to conduct extensive biomarker discovery and clinical research. Furthermore, the region's adoption of cutting-edge technologies and emphasis on precision medicine initiatives are driving up demand for miRNA techniques in the market. Moreover, by allowing for a more detailed examination of miRNA expression, single-cell technologies provide new insights into cellular heterogeneity thus fostering growth.
China miRNA tools and services market is experiencing noteworthy growth attributable to the research to accurately examine the functions of miRNAs by integrating CRISPR/Cas9 technology into miRNA studies, which permits precise genome editing. For instance, in January 2025, China researchers identified integrin subunit alpha 8 (ITGA8) as a key gene responsible for abivertinib sensitivity using a genome-wide CRISPR-Cas9 screen in lung adenocarcinoma cells. After identifying it in the screen, the team showed that ITGA8 delays the development of acquired resistance in H1975 cell xenograft mouse models, increases sensitivity to EGFR-TKIs, and inhibits the proliferation, invasion, and migration of lung adenocarcinoma cells.
India miRNA tools and services market is revolutionizing owing to government programs, legislative changes, and technology breakthroughs. Digital health solutions are essential for improving accessibility, affordability, and efficiency in the face of a rapidly expanding population and rising demand for high-quality healthcare to close the gap between urban and rural healthcare services. For instance, in January 2025, the Ministry of Health and Family Welfare emphasized that Indian programs such as the Digital Health Incentive Scheme (DHIS) and the Ayushman Bharat Digital Mission (ABDM), can establish a global standard for the transformation of digital healthcare.
Companies Dominating the miRNA Tools and Services Landscape
- Abcam plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific
- Agilent Technologies
- Qiagen
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- PerkinElmer, Inc.
- Takara Bio Inc.
- New England Biolabs
- NanoString Technologies, Inc.
- Exiqon (Qiagen)
- GeneCopoeia, Inc.
- Promega Corporation
- Roche Diagnostics
The miRNA tools and services market is dominated by a thriving ecosystem of both new and established players. To expand their product lines and offer end-to-end solutions for functional characterization, analysis, and profiling, large biotech companies are investing heavily in the development of complex miRNA technologies. For instance, in July 2024, CureVac N.V. and GSK plc announced that they have reorganized their current partnership (since 2020) into a new licensing agreement, enabling each business to concentrate its mRNA development efforts and prioritize investment.
Here's the list of some key players:
In the News
- In January 2025, Illumina, Inc. announced to partner with NVIDIA to develop technology platforms for multiomic data analysis and interpretation. This partnership will speed up advancements in drug discovery, clinical research, and genomics AI development.
- In September 2024, Takara Bio USA, Inc., announced the introduction of the SmartChip NDTM Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR solution for monitoring antimicrobial resistance (AMR).
Author Credits: Radhika Pawar
- Report ID: 7264
- Published Date: Mar 03, 2025
- Report Format: PDF, PPT
